Advancing Diabetes Care: The Future of Continuous Glucose Monitoring in the Management of Diabetes : Episode 1
Opinion
Video
CGM: Redefining Type 2 Diabetes Management
Author(s):
A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing real-time data that enables earlier interventions, supports treatment optimization, and helps managed care organizations justify broader CGM adoption for newly diagnosed patients.
Video content above is prompted by the following:
- What are the primary barriers to achieving early and consistent glycemic control in T2D patients?
- How can CGM technology help clinicians address therapeutic inertia in diabetes care?
- What role does CGM play in reducing the time patients spend with suboptimal glucose management?
- How can managed care organizations support earlier adoption of CGM in newly diagnosed T2D patients?
Related Videos
Related Content
